Insulin aspart, recombinant Subcutaneous and Zemplar (Paricalcitol Capsules)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zemplar (Paricalcitol Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Zemplar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zemplar (Paricalcitol Injection)
- Insulin aspart, recombinant Subcutaneous-Zemplar Injection
- Insulin aspart, recombinant Subcutaneous-Zemplar Intravenous
- Insulin aspart, recombinant Subcutaneous-Zemuron
- Insulin aspart, recombinant Subcutaneous-Zenapax
- Insulin aspart, recombinant Subcutaneous-Zenatane
- Zemplar (Paricalcitol Capsules)-Insulin degludec
- Zemplar (Paricalcitol Capsules)-Insulin Degludec (U-100) Prefilled Pens
- Zemplar (Paricalcitol Capsules)-Insulin Degludec (U-100) Vials
- Zemplar (Paricalcitol Capsules)-Insulin Degludec (U-200) Prefilled Pens
- Zemplar (Paricalcitol Capsules)-Insulin degludec and liraglutide
- Zemplar (Paricalcitol Capsules)-Insulin degludec and liraglutide Subcutaneous